ad image

Company Info

PPD, part of Thermo Fisher Scientific

PPD, part of Thermo Fisher Scientific

Clinical CRO

Overview

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With more than 28,000 professionals worldwide, PPD has conducted clinical trials in more than 100 countries to help customers deliver life-changing therapies to improve health. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value. For more information, visit www.ppd.com.
PPD, part of Thermo Fisher Scientific
Contributions
33 Contributions1 / 2
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.

PPD, part of Thermo Fisher Scientific

PAO-08-24-CL-05Sep 16, 2024
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Cell and Gene Therapy

Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies

Erin Schaller; Aidan Jones

PPD, part of Thermo Fisher Scientific

PAO-06-24-CL-11Jul 09, 2024
An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World
Decentralized Clinical Trials

An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World

Richie Pfeiffer

PPD, part of Thermo Fisher Scientific

PAO-12-23-CL-08Jan 17, 2024
Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models
Sustainable Clinical Trials

Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models

Michael J. Cohen

PPD, part of Thermo Fisher Scientific

PAO-12-23-CL-05Dec 13, 2023
Innovating DCTs Through Application and Cross-Functional Delivery
Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

Jennifer Crager; Sandra Orset, Ph.D.

PPD, part of Thermo Fisher Scientific

PAO-07-23-CL-02Aug 29, 2023
Enhance Patient Engagement in Decentralized Trials with Home Healthcare Solutions
Home Healthcare in DCTs

Enhance Patient Engagement in Decentralized Trials with Home Healthcare Solutions

Eve Kamau MSc, RN

PPD, part of Thermo Fisher Scientific

PAO-06-23-CL-01Jul 11, 2023
Interest in Decentralized Trials Rising in Asia-Pacific
Asia-Pacific DCTs

Interest in Decentralized Trials Rising in Asia-Pacific

Ryan Jiang; Shiho Yamanaka; Wai Hong Yuen; Eve Kamau MSc, RN

PPD, part of Thermo Fisher Scientific

PAO-11-022-CL-10Dec 02, 2022
Reducing the Challenges Sites Face when Implementing Decentralized Trials
Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

PAO-11-022-CL-05Nov 17, 2022
The Evolving Role of Remote Monitoring
Decentralized Clinical Trials

The Evolving Role of Remote Monitoring

PPD, part of Thermo Fisher Scientific

PAO-11-22-PATV-02Nov 17, 2022
Exploring Challenges and Considerations for Operationalizing DCTs in the European Union
European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

PAO-09-022-CL-07Oct 06, 2022
Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants
Neurodegenerative Disease Clinical Trials

Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants

John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.

PPD, part of Thermo Fisher Scientific

PAO-09-022-CL-09Sep 27, 2022
Evolving Solutions to Optimize Clinical Trial Decentralization
Clinical Trials Adherence

Evolving Solutions to Optimize Clinical Trial Decentralization

Tim Rich; John Musaus

PPD, part of Thermo Fisher Scientific

PAO-09-022-CL-06Sep 24, 2022
Rare Disease Patients Benefit from Clinical Trial Flexibility
Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

Tim Rich; Meredith McCumbee; Francis Jones, Ph.D.

PPD, part of Thermo Fisher Scientific

PAO-02-022-CL-03Mar 12, 2022
Closing the Gender Gap in Clinical Research
Women's Health

Closing the Gender Gap in Clinical Research

John M. Manns; Rose Blackburne, M.D., MBA; Davide Garrisi, D.Ph.C.

PPD, part of Thermo Fisher Scientific

PAO-02-022-CL-17-627Mar 10, 2022
PPD’s Approach to Practical Translational Medicine
Translational Medicine

PPD’s Approach to Practical Translational Medicine

Jeffrey Wheeler; Darin Brimhall, D.O., FACP

PPD, part of Thermo Fisher Scientific

PAO-11-21-CL-03Nov 10, 2021
How Can Oncology Trials Be Decentralized?
Decentralized Clinical Trials

How Can Oncology Trials Be Decentralized?

PPD, part of Thermo Fisher Scientific

PAO-10-21-CL-16Oct 27, 2021
Estimands in Oncology Trials
Oncology Clinical Trials

Estimands in Oncology Trials

PPD, part of Thermo Fisher Scientific

PAO-10-21-CL-07Oct 13, 2021
A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research
Decentralized Clinical Trials

A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research

Tim Rich; Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.; Jenna McDonnell

PPD, part of Thermo Fisher Scientific

PAO-10-21-CL-04Oct 12, 2021
Complex Early Development Studies — Managing FIH to Phase Ib
Early Development Studies

Complex Early Development Studies — Managing FIH to Phase Ib

Karen McCarthy

PPD, part of Thermo Fisher Scientific

PAO-08-21-CL-04Aug 17, 2021
Preparing to Face the Next Global Challenge: Studying Post-Acute COVID-19 Syndrome
Post-Acute COVID-19 Syndrome

Preparing to Face the Next Global Challenge: Studying Post-Acute COVID-19 Syndrome

Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.; Margaret Vernon, Ph.D.; Sudhakar Sridharan, M.D.; Andrew Burr, Ph.D. M.I.C.R., C.Biol., F.R.S.B; Cristina Nieto; Davide Garrisi, D.Ph.C.

PPD, part of Thermo Fisher Scientific

PAO-06-21-CL-02Jun 14, 2021
1 / 2
49 Contributors1 / 3
Mariah Baltezegar

Mariah Baltezegar

Vice President, Peri- and Post-Approval Study Innovation

Patrick Bennett

Patrick Bennett

Vice President, Laboratory Strategy and Operations

Rose Blackburne, M.D., MBA

Rose Blackburne, M.D., MBA

Vice President, Global Head General Medicine & Women’s Health

Darin Brimhall, D.O., FACP

Darin Brimhall, D.O., FACP

Strategic Medical Director, Early Development

Andrew Burr, Ph.D. M.I.C.R., C.Biol., F.R.S.B

Andrew Burr, Ph.D. M.I.C.R., C.Biol., F.R.S.B

Vice President, Infections & Respiratory Disease Therapeutic Unit Head

Jennifer Christiansen, Ph.D.

Jennifer Christiansen, Ph.D.

Senior Director and Deputy Pillar Head, Ophthalmology

Simon Coggins, Ph.D.

Simon Coggins, Ph.D.

Vice President, Biopharma Business Segment Lead, Hematology and Oncology Therapeutic Unit

Michael J. Cohen

Michael J. Cohen

Senior Director, Sustainable Trials, Strategy & Innovation, Digital & Decentralized Solutions

Karin Coyne, Ph.D., MPH

Karin Coyne, Ph.D., MPH

Vice President, Patient-Centered Research, Evidera

Jennifer Crager

Jennifer Crager

Executive Director of Implementation, Digital and Decentralized Solutions (D&DS)

Alistair Davidson

Alistair Davidson

Executive Director, Regulatory Intelligence and Delivery Solutions, Regulatory Affairs

Brittany Erana

Brittany Erana

Vice President, PPD Digital

Zoé Felicié

Zoé Felicié

Senior Project Manager of Patient Diversity

Davide Garrisi, D.Ph.C.

Davide Garrisi, D.Ph.C.

Executive Director, General Medicine

John Hamlet

John Hamlet

Executive Director, Neuroscience

Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.

Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.

Vice President and Global Therapeutic Head, Respiratory, Global Product Development

Tammy Jackson

Tammy Jackson

Executive Director, Innovation and Digital Operations

Ryan Jiang

Ryan Jiang

Associate Director, Digital Strategy & Technology Innovation

Daniel Jones

Daniel Jones

Vice President, Clinical Management

Francis Jones, Ph.D.

Francis Jones, Ph.D.

Senior Director, DCT Strategy and Innovation, Digital and Decentralized Solutions

1 / 3